人類血小板裂解物市場規模、佔有率和成長分析（按類型、應用、最終用戶和地區）-產業預測（2025-2032）

Human Platelet Lysate Market Size, Share, and Growth Analysis, By Type, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年08月19日 | 出版商:

SkyQuest | 英文 186 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計 2023 年全球人類血小板裂解物市場規模將達到 2 億美元，從 2024 年的 2.24 億美元成長到 2032 年的 5.5462 億美元，預測期內（2025-2032 年）的複合年成長率為 12.0%。

受間間質幹細胞療法研究和生物加工技術創新的推動，全球人類血小板裂解物 (HPL) 市場正在經歷顯著成長。作為向再生醫學和細胞療法廣泛轉變的體現，HPL 在臨床環境中的應用正在增加。隨著世界各國政府優先投資幹細胞研究，HPL 技術的應用也日益受到重視。此外，HPL 製造方法的最新進展，例如引入人工 HPL 溶液和先進的冷凍乾燥技術，有助於提高產品的一致性、安全性和擴充性。這些趨勢凸顯了 HPL 市場的動態演變，並使 HPL 成為推動治療應用發展的關鍵參與者。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2024年）
主要企業採取的策略
近期市場趨勢
主要企業市場佔有率（2024年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分析市場佔有率
- 收益同比對比（2022-2024 年）

主要企業簡介

Compass Biomedical, Inc.
Mill Creek Life Sciences, LLC
Macopharma SA
Merck KGaA
ZenBio, Inc.
PL BioScience GmbH
Cook Regentec
Trinova Biochem GmbH
Stemcell Technologies Inc.
AventaCell BioMedical Co., Ltd.
Biological Industries USA, Inc.
ScienCell Research Laboratories, Inc.
Regenexx
Thermo Fisher Scientific Inc.
Corning Incorporated

結論和建議

簡介目錄

Product Code: SQMIG35H2366

Global Human Platelet Lysate Market size was valued at USD 200.0 million in 2023 and is poised to grow from USD 224.0 million in 2024 to USD 554.62 million by 2032, growing at a CAGR of 12.0% during the forecast period (2025-2032).

The global Human Platelet Lysate (HPL) market is witnessing significant growth driven by heightened research in mesenchymal stem cell therapies and innovations in bioprocessing techniques. There is an increasing adoption of HPL in clinical settings, reflecting a broader shift towards regenerative medicine and cell therapy initiatives. As governments worldwide prioritize investments in stem cell research, the deployment of HPL technologies is becoming more prominent. Additionally, recent advancements in HPL production methods, including the introduction of artificial HPL solutions and refined lyophilization techniques, are contributing to enhanced consistency, safety, and scalability of products. These trends highlight the dynamic evolution of the HPL market, positioning it as a key player in the advancement of therapeutic applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Platelet Lysate market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Human Platelet Lysate Market Segments Analysis

Global Human Platelet Lysate Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into Heparin-Based Human Platelet Lysate and Heparin-Free Human Platelet Lysate. Based on Application, the market is segmented into Research Use and Clinical/Therapeutic Use. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Human Platelet Lysate Market

The Global Human Platelet Lysate market is experiencing growth as regulatory agencies increasingly discourage the use of animal-derived components in therapeutic applications. This shift is particularly evident in regions like North America and Europe, where there is a strong emphasis on xeno-free and ethically sourced materials. Human platelet lysate (HPL) has emerged as a favored alternative to fetal bovine serum, primarily due to its reduced immunogenicity and its alignment with Good Manufacturing Practice (GMP) standards. As researchers and clinicians prioritize safety and ethical considerations, the adoption of HPL in stem cell research and clinical trials is expanding significantly.

Restraints in the Global Human Platelet Lysate Market

The Global Human Platelet Lysate market faces significant restraints that hinder its growth, primarily due to the high production costs associated with its manufacturing. Additionally, the inconsistency in composition across different batches poses challenges regarding reproducibility in research, as well as complicating the scaling process for therapeutic applications. These variabilities contribute to a cautious approach among smaller to mid-sized research and biotech companies, as the demand for stringent quality control measures and compliance with Good Manufacturing Practices adds complexity to the manufacturing process. As a result, the widespread adoption of human platelet lysate is impeded, limiting its clinical utilization.

Market Trends of the Global Human Platelet Lysate Market

The Global Human Platelet Lysate market is witnessing a significant shift towards heparin-free and xeno-free formulations, driven by heightened regulatory scrutiny and demand for ethically sourced alternatives. Manufacturers are increasingly focusing on developing chemically defined substitutes that enhance safety and standardization in cell culture practices. This transition is reshaping clinical research and therapeutic manufacturing landscapes, as stakeholders prioritize safer methodologies and sustainable sourcing. The industry's commitment to innovation in HPL products is expected to fuel market growth, reflecting a broader trend towards improved quality and compliance in biomedical applications.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Human Platelet Lysate Market Size by Type & CAGR (2025-2032)

Market Overview
Heparin-Based Human Platelet Lysate
Heparin-Free Human Platelet Lysate

Global Human Platelet Lysate Market Size by Application & CAGR (2025-2032)

Market Overview
Research Use
Clinical/Therapeutic Use

Global Human Platelet Lysate Market Size by End User & CAGR (2025-2032)

Market Overview
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations (CROs)

Global Human Platelet Lysate Market Size & CAGR (2025-2032)

North America (Type, Application, End User)
- US
- Canada
Europe (Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Compass Biomedical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mill Creek Life Sciences, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Macopharma SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZenBio, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PL BioScience GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Regentec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinova Biochem GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stemcell Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AventaCell BioMedical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological Industries USA, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ScienCell Research Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regenexx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments